11.27.23 -- Emerging Market Trends For Delivery Devices

Degradable polymers have evolved from aliphatic polyesters to nitrogen-containing biomaterials. Here is a brief history of the development of PEA polymers.

Learn how sterile injectable devices are providing safer and more convenient self-injection delivery, leading to positive patient experiences, better therapy adherence, and improved outcomes.

By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.

Explore how to approach the transition of migrating from a vial to a syringe or cartridge, the necessary compatibility testing, and the stresses on the bulk product during formulation and filling.

Drug delivery is one of the most significant obstacles to advancing gene therapies. Examine the opportunities for success in combining novel medical devices to improve delivery of gene therapies.

Learn how to expedite the development pathway for early-phase compounds and how lipid-based formulations provide an innovative approach to enhance bioavailability for challenging molecules.

Review considerations for collaborating with a fill/finish CMO, including CMO selection, request for proposal (RFP) delivery, proposal review, and project award.

Do you want to develop an oral controlled release (OCR) product? Understand the options and their ramifications as the first step toward devising a plan.